AEGLE THERAPEUTICS

In News

Aegle Therapeutics Names Industry Veteran Scott Braunstein, M.D. as Chairman of the Board - GlobeNewswire

GlobeNewswire - Jul 15, 2025

Clinical trials underway for stem cell-derived ointment for blistering skin disorders - Refresh Miami

Refresh Miami - May 16, 2025

The Emerging Role of Exosome Therapeutics in 2026 - BioInformant

BioInformant - Oct 27, 2025

Exosomes are finding new life as the field solves for manufacturing - biocentury.com

biocentury.com - Apr 03, 2025

Aegle Therapeutics Corp. Announces Positive Data for the First Patient in a Phase 1/2a Clinical Trial Dosed With AGLE-102™, a Novel Extracellular Vesicle Therapy - PR Newswire

PR Newswire - Jan 08, 2024

Six exosome therapy companies driving development in the field - Labiotech.eu

Labiotech.eu - Nov 14, 2024

Aegle Therapeutics Prepares Phase 1/2a Trial of BM-MSC Derived Extracellular Vesicles - BioInformant

BioInformant - Jul 20, 2018

Systematic Evaluation of Aegle marmelos-Derived Compounds: Potential Therapeutic Agents Against Inflammation and Oxidative Stress - Cureus

Cureus - Apr 03, 2024

Therapeutic effect of Aegle marmelos fruit extract against DMBA induced breast cancer in rats - Nature

Nature - Oct 22, 2020

Miami biotech startup Aegle Therapeutics draws $4M investment round - Refresh Miami

Refresh Miami - Jan 08, 2020

Aegle Therapeutics Raises $4M to Fund First Trial in the U.S. Using Exosomes from Allogeneic MSCs - BioInformant

BioInformant - Jan 11, 2020

Aegle Therapeutics’ big mission: Tackling a horrific pediatric disorder - Refresh Miami

Refresh Miami - Dec 02, 2020

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment